Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Drug Interactions MOUNJARO delays gastric emptying and has the potential to impact the absorption of concomitantly administered oral medications
Phase 2 tirzepatide dose-ranging in T2D 1, 5, 10, and 15 mg over 26 weeks
Dosage Forms and Strengths Injection: Clear, colorless to slightly yellow solution in pre-filled single-dose pens, single-dose vials, multi-dose vials, or single-patient-use KwikPens, each available in the following strengths
Clinical trials have shown that these medications reduce the risk of major cardiovascular events, including heart attack and stroke
US$ 21.26
US$ 25.13
US$ 26.53
US$ 20.24
US$ 26.33
